Redwood Investments LLC Sells 503,124 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Redwood Investments LLC reduced its holdings in Aspen Aerogels, Inc. (NYSE:ASPNFree Report) by 69.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 226,299 shares of the construction company’s stock after selling 503,124 shares during the period. Redwood Investments LLC owned approximately 0.32% of Aspen Aerogels worth $3,571,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ASPN. Advisor Group Holdings Inc. boosted its holdings in Aspen Aerogels by 37.5% during the first quarter. Advisor Group Holdings Inc. now owns 2,539 shares of the construction company’s stock worth $87,000 after buying an additional 692 shares during the last quarter. Bank of New York Mellon Corp raised its position in shares of Aspen Aerogels by 7.2% in the 1st quarter. Bank of New York Mellon Corp now owns 94,868 shares of the construction company’s stock valued at $3,271,000 after acquiring an additional 6,356 shares during the period. MetLife Investment Management LLC boosted its stake in Aspen Aerogels by 56.5% during the 1st quarter. MetLife Investment Management LLC now owns 11,713 shares of the construction company’s stock worth $404,000 after acquiring an additional 4,230 shares during the last quarter. Rhumbline Advisers grew its holdings in Aspen Aerogels by 13.5% during the first quarter. Rhumbline Advisers now owns 22,371 shares of the construction company’s stock valued at $771,000 after purchasing an additional 2,664 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in Aspen Aerogels by 5.0% in the first quarter. Dimensional Fund Advisors LP now owns 441,247 shares of the construction company’s stock valued at $15,214,000 after purchasing an additional 21,112 shares in the last quarter. 97.64% of the stock is owned by institutional investors.

Aspen Aerogels Stock Up 1.4 %

ASPN stock opened at $17.60 on Monday. The company has a debt-to-equity ratio of 0.24, a current ratio of 3.41 and a quick ratio of 2.91. The stock has a market capitalization of $1.35 billion, a P/E ratio of -26.67 and a beta of 2.03. Aspen Aerogels, Inc. has a fifty-two week low of $5.32 and a fifty-two week high of $19.10. The business has a 50-day moving average of $15.11 and a 200-day moving average of $12.10.

Aspen Aerogels (NYSE:ASPNGet Free Report) last released its quarterly earnings results on Tuesday, February 13th. The construction company reported ($0.01) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.11. Aspen Aerogels had a negative return on equity of 10.47% and a negative net margin of 19.19%. The firm had revenue of $84.22 million during the quarter, compared to the consensus estimate of $83.82 million. During the same quarter in the prior year, the firm posted ($0.20) EPS. On average, sell-side analysts anticipate that Aspen Aerogels, Inc. will post -0.24 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on ASPN. HC Wainwright reissued a “buy” rating and set a $20.00 price target on shares of Aspen Aerogels in a research report on Wednesday, February 14th. Canaccord Genuity Group boosted their target price on Aspen Aerogels from $13.00 to $17.00 and gave the company a “buy” rating in a research note on Wednesday, December 27th. Roth Mkm initiated coverage on Aspen Aerogels in a research report on Wednesday, March 6th. They set a “buy” rating and a $22.00 price target on the stock. Canaccord Genuity Group boosted their price objective on Aspen Aerogels from $13.00 to $17.00 and gave the company a “buy” rating in a research report on Wednesday, December 27th. Finally, TheStreet upgraded shares of Aspen Aerogels from a “d+” rating to a “c-” rating in a report on Wednesday, March 6th. One research analyst has rated the stock with a sell rating and five have given a buy rating to the stock. According to data from MarketBeat, Aspen Aerogels has a consensus rating of “Moderate Buy” and an average target price of $19.00.

Get Our Latest Report on ASPN

Aspen Aerogels Company Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Articles

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.